Things seem to be favoring Bayer as a California jury returned with a verdict in favor of the company. A representative for the company confirmed the favorable ruling in the Roundup herbicide lawsuit on Tuesday, October 5th. The jury found that herbicide was not a substantial cause of a child’s rare form of non-Hodgkin’s lymphoma.
The plaintiff, Destiny Clark, alleged that her son Ezra developed Burkitt’s lymphoma after getting exposed to Roundup, which she sprayed on weeds at their family residence. The woman then sued Monsanto, which is owned by Bayer, for failing to warn her of the cancer risks Roundup’s usage posed.
The verdict is the fourth involving Roundup and the first to favor the company. Bayer has been facing lawsuits since it acquired the herbicide as part of its purchase of Monsanto in 2018 for $63 billion. Monsanto is a leading manufacturer of agricultural seeds and agricultural herbicides.
Commenting on the jury’s verdict in this Roundup herbicide lawsuit, Bayer said that the decision was consistent with decades of science and studies on the safety of glyphosate, the primary Roundup ingredient. The company noted that while they have great sympathy for Ezra, the jury painstakingly looked at the science before concluding that Roundup was not the cause of the illness.
So far, Bayer has settled 96,000 Roundup cases out of 125,000. In May, a federal judge rejected the company’s plan to resolve future cases that would compensate victims but limit their right to sue. The herbicide manufacturer is also appealing two out of three verdicts against them, with one before the Supreme Court.
While the lawsuits and appeals persist, anyone who believes they are affected by Roundup can still file a lawsuit. However, a potential plaintiff must meet all the legal and health requirements. Find out what they are by contacting our mass tort lawyers today.